Cspc Ouyi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CSPC OUYI, and what generic and branded alternatives to CSPC OUYI drugs are available?
CSPC OUYI has sixteen approved drugs.
Drugs and US Patents for Cspc Ouyi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cspc Ouyi | CONJUPRI | levamlodipine maleate | TABLET;ORAL | 212895-001 | Dec 19, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Cspc Ouyi | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 211310-001 | Oct 16, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cspc Ouyi | GABAPENTIN | gabapentin | CAPSULE;ORAL | 075477-003 | Mar 23, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.